Finally, consistent with previous meta-analyses33, we did not find any evidence of abnormal D1 receptor and DAT availability in the striatum of schizophrenia, except for one D1 study53 and one DAT study67 that reported decreased in drug-on chronic patients. Here, SLC6A3 is linked to schizophrenia.